Past Tuesday Talks — How a Passionate Investor Battles Auto-Immunity

Tuesday, January 16th, 2023

Presented by Seema Kumar, CEO, Cure

Veteran life sciences investor Gillian Sandler doesn’t just pick great companies. She plunges in with verve and passion, sometimes taking an executive role. This has been the case for her efforts to combat the scourge of auto-immune disorders, which have struck several members of her family. Gillian shared her own insights on the current market environment, and what drives her to help companies develop treatments and cures for debilitating diseases.

Tuesday Talks

When: Tuesday, January 16, 12:30 PM ET
Where: Virtual on LinkedIn LIVE

Topic: A fireside chat to with Gillian Sandler talk auto-immune disorders and current market environments.

Speakers: Gillian Sandler, Managing Partner, Galapont Capital; Trustee of the Columbia Zuckerman Mind Brain Behavior Institute. Moderated by Seema Kumar, CEO of Cure

Featured Speakers

Gillian Sandler

About Gillian Sandler

Gillian Sandler brings 25 years of experience as an entrepreneur, CEO, Chairman, investor, research analyst, author and corporate strategist in the U.S. and internationally, across multiple economic and market cycles, restructurings, and stages of growth and financing.

Seema Kumar

About Seema Kumar

Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.